Bank of America Corp DE Has $108.26 Million Stock Holdings in The Cooper Companies, Inc. (NASDAQ:COO)

Bank of America Corp DE lowered its stake in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 18.5% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 1,177,605 shares of the medical device company's stock after selling 268,014 shares during the period. Bank of America Corp DE owned approximately 0.59% of Cooper Companies worth $108,257,000 as of its most recent filing with the SEC.

Several other large investors have also recently bought and sold shares of COO. Price T Rowe Associates Inc. MD increased its stake in shares of Cooper Companies by 517.0% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 3,529,477 shares of the medical device company's stock worth $324,466,000 after purchasing an additional 2,957,421 shares during the period. Norges Bank acquired a new stake in shares of Cooper Companies during the fourth quarter worth $217,906,000. FMR LLC boosted its position in shares of Cooper Companies by 97.6% in the fourth quarter. FMR LLC now owns 2,218,112 shares of the medical device company's stock valued at $203,911,000 after acquiring an additional 1,095,805 shares during the period. Raymond James Financial Inc. acquired a new position in shares of Cooper Companies in the fourth quarter valued at about $64,826,000. Finally, Victory Capital Management Inc. increased its position in Cooper Companies by 14.6% during the fourth quarter. Victory Capital Management Inc. now owns 4,525,018 shares of the medical device company's stock worth $415,985,000 after acquiring an additional 574,899 shares during the period. 24.39% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of analysts have issued reports on the stock. Needham & Company LLC reissued a "hold" rating on shares of Cooper Companies in a report on Friday, March 7th. BNP Paribas upgraded Cooper Companies to a "hold" rating in a research note on Thursday, March 13th. Stifel Nicolaus cut their target price on Cooper Companies from $115.00 to $105.00 and set a "buy" rating for the company in a research report on Friday, March 7th. Piper Sandler restated an "overweight" rating and issued a $115.00 price target (down previously from $120.00) on shares of Cooper Companies in a research report on Friday, March 7th. Finally, JPMorgan Chase & Co. cut their price objective on shares of Cooper Companies from $120.00 to $110.00 and set an "overweight" rating for the company in a research report on Friday, March 7th. Four analysts have rated the stock with a hold rating and seven have given a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $110.25.

Cooper Companies Trading Down 0.8 %

COO opened at $82.27 on Friday. The company has a market cap of $16.45 billion, a P/E ratio of 42.19, a PEG ratio of 2.25 and a beta of 1.08. The company has a current ratio of 1.91, a quick ratio of 1.12 and a debt-to-equity ratio of 0.32. The company's 50 day moving average is $80.54 and its 200-day moving average is $90.93. The Cooper Companies, Inc. has a 1-year low of $69.81 and a 1-year high of $112.38.

Cooper Companies (NASDAQ:COO - Get Free Report) last issued its earnings results on Thursday, March 6th. The medical device company reported $0.92 earnings per share for the quarter, meeting analysts' consensus estimates of $0.92. The firm had revenue of $964.70 million for the quarter, compared to analyst estimates of $981.25 million. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. Equities research analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.